hydroxyurea has been researched along with Cyanosis in 1 studies
Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.
Excerpt | Relevance | Reference |
---|---|---|
" MCV and HbF were higher among patients receiving HU, the increase in MCV being cumulative with HU dosage but the rise in HbF dose independent." | 1.29 | Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease. ( Casadevall, N; Deschamps, A; Ducrocq, R; Dunda, O; Elion, J; Girot, R; Krishnamoorty, R; Labie, D; Maier-Redelsperger, M; Triadou, P, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Triadou, P | 1 |
Maier-Redelsperger, M | 1 |
Krishnamoorty, R | 1 |
Deschamps, A | 1 |
Casadevall, N | 1 |
Dunda, O | 1 |
Ducrocq, R | 1 |
Elion, J | 1 |
Girot, R | 1 |
Labie, D | 1 |
1 other study available for hydroxyurea and Cyanosis
Article | Year |
---|---|
Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease.
Topics: Adolescent; Adult; Child; Cyanosis; Erythroid Precursor Cells; Erythropoietin; Female; Fetal Hemoglo | 1994 |